Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center
A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip r) Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870 E. coli strains isolated during this period, 257 cip r- E. coli...
Gespeichert in:
| Veröffentlicht in: | Diagnostic microbiology and infectious disease 1997-11, Vol.29 (3), p.133-138 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 138 |
|---|---|
| container_issue | 3 |
| container_start_page | 133 |
| container_title | Diagnostic microbiology and infectious disease |
| container_volume | 29 |
| creator | Canawati, Hanna N. El-Farra, Rula Seymour, Judith Shimashita, John Dunn, Donald Montgomerie, John Z. |
| description | A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip
r)
Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870
E. coli strains isolated during this period, 257 cip
r-
E. coli were recovered from 257 patients. The majority (96%) of these resistant strains were isolated from the urine samples. One hundred and twenty strains of cip
r-
E. coli were also resistant to four other fluoroquinolones. MICs ranging from 64 to 512 μg/mL were observed in 75% of the strains and ≥1028 μg/mL in 6.4% of the strains. Resistance to ciprofloxacin was due to possible mutations in topoisomerase gyrA. |
| doi_str_mv | 10.1016/S0732-8893(97)81802-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79466950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889397818020</els_id><sourcerecordid>79466950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-39ff862a9729e503bb7037fb7b7c7366688efab15d5e2fdfefb909bc1f86cb4e3</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVocRwnP8Gwh1Caw7ajXe9KOpVgnLRg6KHuWUjyyJ6w1qbSOrT_PvIHvvYiHeZ5R3ofxqYcvnDg7ddfIOqqlFLVn5V4kFxCVcIVG3MpVAkg4AMbX5BrdpPSCwCv1AxGbJTPHGjGbDWn19j7rv9rHIUyYqI0mDAUi-S2GMltyRSu76jAHcYNhU1BoTBFxK2x1NFgBupDscM1OdMVDsOA8ZZ99KZLeHe-J-z302I1_14ufz7_mD8uS1dLNZS18l62lVGiUthAba2AWngrrHCibttWSvTG8mbdYOXXHr1VoKzjOeXsDOsJ-3Tamyv82WMa9I6Sw64zAft90kLN2lblzRPWnEAX-5Qiev0aaWfiP81BH2zqo019UKWV0Eeb-pCbnh_Y21zxkjrry_P789ykXN9HExylC1ZxgEocsG8nDLOMN8KokyMMLkuL6Aa97uk_H3kHaLOSnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79466950</pqid></control><display><type>article</type><title>Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Canawati, Hanna N. ; El-Farra, Rula ; Seymour, Judith ; Shimashita, John ; Dunn, Donald ; Montgomerie, John Z.</creator><creatorcontrib>Canawati, Hanna N. ; El-Farra, Rula ; Seymour, Judith ; Shimashita, John ; Dunn, Donald ; Montgomerie, John Z.</creatorcontrib><description>A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip
r)
Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870
E. coli strains isolated during this period, 257 cip
r-
E. coli were recovered from 257 patients. The majority (96%) of these resistant strains were isolated from the urine samples. One hundred and twenty strains of cip
r-
E. coli were also resistant to four other fluoroquinolones. MICs ranging from 64 to 512 μg/mL were observed in 75% of the strains and ≥1028 μg/mL in 6.4% of the strains. Resistance to ciprofloxacin was due to possible mutations in topoisomerase gyrA.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/S0732-8893(97)81802-0</identifier><identifier>PMID: 9401805</identifier><identifier>CODEN: DMIDDZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anti-Infective Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteriology ; Bacteriuria - drug therapy ; Bacteriuria - epidemiology ; Bacteriuria - microbiology ; Biological and medical sciences ; Ciprofloxacin - pharmacology ; DNA Gyrase ; DNA Topoisomerases, Type II - genetics ; Drug Resistance, Microbial ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - epidemiology ; Escherichia coli Infections - microbiology ; Fundamental and applied biological sciences. Psychology ; Genes, Bacterial ; Humans ; Los Angeles - epidemiology ; Medical sciences ; Microbial Sensitivity Tests ; Microbiology ; Mutation ; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains ; Pharmacology. Drug treatments ; Rehabilitation Centers ; Retrospective Studies ; Time Factors</subject><ispartof>Diagnostic microbiology and infectious disease, 1997-11, Vol.29 (3), p.133-138</ispartof><rights>1997</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-39ff862a9729e503bb7037fb7b7c7366688efab15d5e2fdfefb909bc1f86cb4e3</citedby><cites>FETCH-LOGICAL-c389t-39ff862a9729e503bb7037fb7b7c7366688efab15d5e2fdfefb909bc1f86cb4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0732-8893(97)81802-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2100275$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9401805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Canawati, Hanna N.</creatorcontrib><creatorcontrib>El-Farra, Rula</creatorcontrib><creatorcontrib>Seymour, Judith</creatorcontrib><creatorcontrib>Shimashita, John</creatorcontrib><creatorcontrib>Dunn, Donald</creatorcontrib><creatorcontrib>Montgomerie, John Z.</creatorcontrib><title>Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip
r)
Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870
E. coli strains isolated during this period, 257 cip
r-
E. coli were recovered from 257 patients. The majority (96%) of these resistant strains were isolated from the urine samples. One hundred and twenty strains of cip
r-
E. coli were also resistant to four other fluoroquinolones. MICs ranging from 64 to 512 μg/mL were observed in 75% of the strains and ≥1028 μg/mL in 6.4% of the strains. Resistance to ciprofloxacin was due to possible mutations in topoisomerase gyrA.</description><subject>Anti-Infective Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteriology</subject><subject>Bacteriuria - drug therapy</subject><subject>Bacteriuria - epidemiology</subject><subject>Bacteriuria - microbiology</subject><subject>Biological and medical sciences</subject><subject>Ciprofloxacin - pharmacology</subject><subject>DNA Gyrase</subject><subject>DNA Topoisomerases, Type II - genetics</subject><subject>Drug Resistance, Microbial</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - epidemiology</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes, Bacterial</subject><subject>Humans</subject><subject>Los Angeles - epidemiology</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Mutation</subject><subject>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</subject><subject>Pharmacology. Drug treatments</subject><subject>Rehabilitation Centers</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1rGzEQhkVocRwnP8Gwh1Caw7ajXe9KOpVgnLRg6KHuWUjyyJ6w1qbSOrT_PvIHvvYiHeZ5R3ofxqYcvnDg7ddfIOqqlFLVn5V4kFxCVcIVG3MpVAkg4AMbX5BrdpPSCwCv1AxGbJTPHGjGbDWn19j7rv9rHIUyYqI0mDAUi-S2GMltyRSu76jAHcYNhU1BoTBFxK2x1NFgBupDscM1OdMVDsOA8ZZ99KZLeHe-J-z302I1_14ufz7_mD8uS1dLNZS18l62lVGiUthAba2AWngrrHCibttWSvTG8mbdYOXXHr1VoKzjOeXsDOsJ-3Tamyv82WMa9I6Sw64zAft90kLN2lblzRPWnEAX-5Qiev0aaWfiP81BH2zqo019UKWV0Eeb-pCbnh_Y21zxkjrry_P789ykXN9HExylC1ZxgEocsG8nDLOMN8KokyMMLkuL6Aa97uk_H3kHaLOSnw</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Canawati, Hanna N.</creator><creator>El-Farra, Rula</creator><creator>Seymour, Judith</creator><creator>Shimashita, John</creator><creator>Dunn, Donald</creator><creator>Montgomerie, John Z.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971101</creationdate><title>Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center</title><author>Canawati, Hanna N. ; El-Farra, Rula ; Seymour, Judith ; Shimashita, John ; Dunn, Donald ; Montgomerie, John Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-39ff862a9729e503bb7037fb7b7c7366688efab15d5e2fdfefb909bc1f86cb4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Anti-Infective Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteriology</topic><topic>Bacteriuria - drug therapy</topic><topic>Bacteriuria - epidemiology</topic><topic>Bacteriuria - microbiology</topic><topic>Biological and medical sciences</topic><topic>Ciprofloxacin - pharmacology</topic><topic>DNA Gyrase</topic><topic>DNA Topoisomerases, Type II - genetics</topic><topic>Drug Resistance, Microbial</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - epidemiology</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes, Bacterial</topic><topic>Humans</topic><topic>Los Angeles - epidemiology</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Mutation</topic><topic>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</topic><topic>Pharmacology. Drug treatments</topic><topic>Rehabilitation Centers</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canawati, Hanna N.</creatorcontrib><creatorcontrib>El-Farra, Rula</creatorcontrib><creatorcontrib>Seymour, Judith</creatorcontrib><creatorcontrib>Shimashita, John</creatorcontrib><creatorcontrib>Dunn, Donald</creatorcontrib><creatorcontrib>Montgomerie, John Z.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canawati, Hanna N.</au><au>El-Farra, Rula</au><au>Seymour, Judith</au><au>Shimashita, John</au><au>Dunn, Donald</au><au>Montgomerie, John Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>29</volume><issue>3</issue><spage>133</spage><epage>138</epage><pages>133-138</pages><issn>0732-8893</issn><eissn>1879-0070</eissn><coden>DMIDDZ</coden><abstract>A retrospective review of laboratory records from 1988 to 1996 has shown an increased rate of ciprofloxacin-resistant (cip
r)
Escherichia coli in our rehabilitation center. Resistance increased from 0.6% in 1989 to 5.9% in 1996. Of 7870
E. coli strains isolated during this period, 257 cip
r-
E. coli were recovered from 257 patients. The majority (96%) of these resistant strains were isolated from the urine samples. One hundred and twenty strains of cip
r-
E. coli were also resistant to four other fluoroquinolones. MICs ranging from 64 to 512 μg/mL were observed in 75% of the strains and ≥1028 μg/mL in 6.4% of the strains. Resistance to ciprofloxacin was due to possible mutations in topoisomerase gyrA.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9401805</pmid><doi>10.1016/S0732-8893(97)81802-0</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-8893 |
| ispartof | Diagnostic microbiology and infectious disease, 1997-11, Vol.29 (3), p.133-138 |
| issn | 0732-8893 1879-0070 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79466950 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Infective Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteriology Bacteriuria - drug therapy Bacteriuria - epidemiology Bacteriuria - microbiology Biological and medical sciences Ciprofloxacin - pharmacology DNA Gyrase DNA Topoisomerases, Type II - genetics Drug Resistance, Microbial Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli - genetics Escherichia coli Infections - drug therapy Escherichia coli Infections - epidemiology Escherichia coli Infections - microbiology Fundamental and applied biological sciences. Psychology Genes, Bacterial Humans Los Angeles - epidemiology Medical sciences Microbial Sensitivity Tests Microbiology Mutation Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains Pharmacology. Drug treatments Rehabilitation Centers Retrospective Studies Time Factors |
| title | Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A59%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ciprofloxacin-resistant%20Escherichia%20coli%20emerging%20in%20a%20rehabilitation%20medical%20center&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Canawati,%20Hanna%20N.&rft.date=1997-11-01&rft.volume=29&rft.issue=3&rft.spage=133&rft.epage=138&rft.pages=133-138&rft.issn=0732-8893&rft.eissn=1879-0070&rft.coden=DMIDDZ&rft_id=info:doi/10.1016/S0732-8893(97)81802-0&rft_dat=%3Cproquest_cross%3E79466950%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79466950&rft_id=info:pmid/9401805&rft_els_id=S0732889397818020&rfr_iscdi=true |